Authors
Alexandria L Soto, Isaac S Alderete, Mary Moya-Mendez, Haoran Jiang, Samantha E Halpern, Ewout Muylle, Kentaro Nakata, Kunal J Patel, Jacob Klapper, Hiroshi Date, Matthew G Hartwig
Published in
Clinical transplantation. Volume 40. Issue 11.
Abstract
In March 2023, the Composite Allocation Score (CAS) was introduced to address lung allocation disparities. While CAS outcomes have been reported in adults, its impact on pediatric candidates is poorly examined. This study compares pediatric recipient, donor, and transplant characteristics before and after CAS, with particular attention given to waitlist outcomes and transplantation rates.
The UNOS registry was queried for pediatric lung transplant recipients (<18 years) between June 2021 and December 2024. Continuous variables were analyzed using student-t or Wilcoxon tests, and categorical with Fisher's exact. Survival was analyzed using Kaplan-Meier curves.
Eighty-two pediatric lung transplant recipients were identified (Pre-CAS = 36; Post-CAS = 46). In the Post-CAS era, pediatric lung transplant rate increased (103.5 vs. 240.0 transplants per 100 patient-years; p<0.001), median donor age increased (14.0 vs. 19.5 years; p = 0.0003), median waitlist time decreased (74 days vs. 149 days; p = 0.023), median travel distance increased (388.5 vs. 428.0 miles; p = 0.21), and ischemic time increased (5.7 vs. 6.3 h; p = 0.014). However, graft survival at six months was not significantly different between eras (LAS = 91.7% vs. CAS = 83.7%; p = 0.30).
Implementation of continuous distribution was associated with a higher transplant rate and shorter waitlist times in pediatric lung transplantation. Graft survival did not worsen under CAS, despite increased median travel distance and ischemic times.
PMID:
43019034
Bibliographic data and abstract were imported from PubMed on 13 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 4
- Comments 0